Related by context. All words. (Click for frequent words.) 66 obesity sedentary lifestyle 65 hypertension diabetes mellitus 64 elevated fasting glucose 64 potentially modifiable 64 cardiovascular disease hypertension 63 Erythropoietic therapies may 63 hypertension hypercholesterolemia 63 abnormal lipids 63 abnormal lipid 62 impaired glucose metabolism 62 diabetes mellitus hypertension 62 hyperlipidaemia 62 abnormal lipid levels 61 diabetes dyslipidemia 61 diabetes hypertension hyperlipidemia 60 diabetes hyperlipidemia 60 antidiabetic medications 60 apolipoprotein E4 60 serum leptin 60 fat emboli 60 plasma lipids 60 central adiposity 60 metabolic abnormalities 60 atherogenic dyslipidemia 60 hypertension cardiovascular disease 60 elevated triglycerides 59 elevated triglyceride levels 59 obesity insulin resistance 59 macrovascular disease 59 macrovascular complications 59 postoperative AF 59 PLX STROKE targeting 59 hypercalciuria 59 colorectal adenoma 59 metabolic disturbances 59 nonischemic 59 shorter telomere length 59 serum triglycerides 59 endothelial activation 59 chronic thromboembolic pulmonary 59 G6PD deficiency 59 comorbid illnesses 59 treatment emergent hyperglycemia 59 hypoxemia 58 Untreated sleep apnea 58 carotid plaques 58 hemoglobinopathies 58 hereditary predisposition 58 ischemic complications 58 hypertension congestive heart 58 atherothrombosis 58 onset diabetes mellitus 58 abnormal glucose tolerance 58 glycated hemoglobin levels 58 microvascular disease 58 myocardial infarction ventricular fibrillation 58 lipid abnormalities 58 Genetic variants 58 dysglycemia 58 Stimulant drugs 58 insulin resistance syndrome 58 hyperlipemia 58 lipid lowering agents 58 prostate cancer CaP 58 nicotine metabolite 58 Coronary artery calcification 58 oral hypoglycemic agents 58 carotid bruit 58 nonfasting triglyceride levels 58 thrombophilia 58 hypercholesterolaemia 58 hypokalemia hypomagnesemia 58 causal pathway 58 torsade de pointes 58 psychiatric comorbidities 58 vascular dysfunction 58 Endothelial dysfunction 58 abdominal adiposity 58 gestational diabetes mellitus 58 potential confounders 58 perinatal morbidity 58 fasting hyperglycemia 58 intracerebral haemorrhage 58 dyslipidemia abnormal 58 depression suicidal ideation 58 nonhematologic adverse reactions 58 thrombo embolic 58 comorbid depression 58 thromboembolic disease 57 beta blockers ACE inhibitors 57 Secondhand smoke exposure 57 HDL cholesterol triglycerides 57 arterial calcification 57 macrovascular events 57 de ath 57 CVD mortality 57 myocardial ischaemia 57 hypertensives 57 sociodemographic factors 57 CHD CVD 57 Heavy snorers 57 cardiovascular comorbidities 57 ventricular hypertrophy 57 diabetic kidney 57 modifiable lifestyle 57 comorbid conditions 57 leptin deficiency 57 angina myocardial infarction 57 SE alleles 57 antiplatelet medications 57 autonomic dysfunction 57 amputation blindness 57 myocardial infarction stroke 57 convulsive disorders 57 hypercoagulable 57 serum lipid levels 57 pancreas esophagus 57 unfavorable prognostic 57 Tasigna prolongs 57 hormonal abnormalities 57 cardiovascular morbidity 57 left ventricular hypertrophy 57 predisposing factor 57 baseline serum creatinine 57 atherosclerotic cardiovascular 57 induce orthostatic hypotension 57 hyperhomocysteinemia 57 highest tertile 57 asymptomatic bacteriuria 57 thromboxane A2 57 preeclampsia gestational diabetes 57 ABCB1 56 thromboembolic complications 56 thrombocytopenic 56 hyperlipidemia hypertension 56 distal colon cancer 56 adenomatous polyps 56 testicular tumors 56 Orthostatic hypotension 56 diabetic microvascular complications 56 KIF6 carriers 56 valvular heart disease 56 prostate carcinogenesis 56 MetS 56 antiarrhythmic medications 56 nonfatal myocardial infarction MI 56 gastric cardia 56 dyslipidaemia 56 atherothrombotic 56 dyslipidemia hypertension diabetes 56 cirrhosis liver failure 56 lipid concentrations 56 retinopathy nephropathy 56 reproductive tract infections 56 ischemic cardiovascular 56 Severe hypoglycemia 56 insulin resistance precursor 56 coronary artery atherosclerosis 56 cardiometabolic risk 56 HMGA1 56 dyslipidemias 56 confidence interval #.#-#.# 56 β blockers 56 impaired cognition 56 familial hypercholesterolemia 56 Genetic predisposition 56 Impaired glucose tolerance 56 urgent coronary revascularization 56 Angiograms carry slight 56 postmenopausal hormone 56 fatal IHD 56 systolic blood pressures 56 blood glucose concentrations 56 coronary revascularization procedures 56 inversely associated 56 unmeasured confounders 56 progressive dyspnea 56 infarction NSTEMI 56 carotid atherosclerosis 56 myocardial infarction MI 56 familial pancreatic cancer 56 ovarian dysfunction 56 HF hospitalization 56 NHANES III 56 sociodemographic characteristics 56 lipid elevations 56 subclinical atherosclerosis 56 obesity dyslipidemia 56 untreated hypothyroidism 56 macrovascular 56 metabolic dysfunction 56 physiologic parameters 56 blindness amputations 56 noncardiac 56 obstructive coronary artery 56 lipid levels 56 NIASPAN 56 root caries 56 elevated IOP 56 endometriosis ovarian cysts 56 transferrin saturation 56 gallbladder disease 56 lipoprotein metabolism 56 hypertension dyslipidemia 56 fetal malformations 56 silent myocardial ischemia 56 electrolyte abnormalities 55 cystic fibrosis chronic pancreatitis 55 modifiable risk 55 renal insufficiency 55 cerebrovascular diseases 55 symptomatic ischemic 55 thromboembolism 55 hyperglycaemia 55 thyroid hormone levels 55 lipohypertrophy 55 pancreas secretes insulin 55 folate metabolism 55 plasma triglycerides 55 angiotensin II receptor blockers 55 fasting triglycerides 55 antidiabetic drugs 55 sulphonylureas 55 Myocardial infarction 55 cardioembolic stroke 55 affective disorders 55 chronic obstructive lung 55 fatal myocardial infarction 55 transfusion syndrome 55 cardiovascular hospitalizations 55 intracranial atherosclerosis 55 comorbid psychiatric 55 diabetic hypertensive 55 T1DM 55 VLDL cholesterol 55 artery stenosis 55 containing diphenhydramine brompheniramine 55 multi factorial disease 55 cardiopulmonary diseases 55 CC genotype 55 venous thromboembolic disease 55 nonalcoholic steatohepatitis NASH 55 ATACAND 55 elevated serum creatinine 55 fibroids endometriosis 55 decompensated cirrhosis 55 variant angina 55 metabolic syndromes 55 Maternal obesity 55 myocardial infarction congestive heart 55 nonsteroidal antiinflammatory drugs 55 Cardiopulmonary bypass 55 antidiabetic medication 55 myocardial infarctions 55 waist circumference WC 55 liver steatosis 55 Sedentary lifestyle 55 non cirrhotic portal 55 symptomatic VTE 55 mild renal insufficiency 55 postoperative pulmonary 55 colorectal neoplasia 55 glycosylated hemoglobin HbA1c 55 gallstone disease 55 TT genotype 55 preserved ejection fraction 55 thyrotropin 55 endogenous hormones 55 lipid parameters 55 visceral adiposity 55 oral antidiabetic medication 55 Angiotensin receptor blockers 55 chronic obstructive airway 55 endometrial hyperplasia 55 nonalcoholic steatohepatitis 55 impaired insulin secretion 55 serum potassium 55 nondiabetic subjects 55 arterial inflammation 55 Ischemic heart 55 cardiac malformations 55 metabolic parameters 55 Cognitive impairment 55 methemoglobinemia 55 elevated hsCRP 55 cardiac tamponade cerebral edema 55 multivessel disease 55 atrial tachyarrhythmias 55 Vitamin B# deficiency 55 angina chest 55 extrapyramidal symptoms 55 2 diabetes T2D 55 ventricular tachyarrhythmia 55 clinically meaningful reductions 55 Nonalcoholic fatty liver 55 predisposing factors 55 GSTT1 55 cardiac insufficiency 55 β blocker 55 metformin sulphonylurea 55 anorexia nervosa bulimia 55 ß blockers 55 MTHFR 55 serotonin neurotransmission 55 prothrombotic 55 left ventricular dysfunction 55 COPD asthma 55 oxidized cysteine 55 systolic hypertension 55 NUCYNTA ™ 55 noncardiovascular mortality 55 LV dysfunction 55 cervicitis 55 overt nephropathy 55 BMI z 55 lipoprotein levels 55 elevated creatine phosphokinase 55 thalassemia sickle cell 55 serum triglyceride levels 55 adenocarcinoma histology 55 co morbidities 54 Sleep disordered breathing 54 NNT = 54 Thiazolidinediones 54 dysrhythmias 54 cerebrovascular ailments 54 diastolic blood pressures 54 resuscitated cardiac arrest 54 lowest tertile 54 fasting glucose levels 54 serum GGT 54 breast endometrial 54 intima media thickness 54 Aldosterone 54 cause cardiac channelopathies 54 abnormal vaginal bleeding 54 hepatorenal syndrome 54 circulating estrogens 54 arterial stiffening 54 comorbid 54 Darapladib 54 intact parathyroid hormone 54 comorbidity 54 coronary revascularization 54 fetal chromosomal 54 inflammatory biomarkers 54 total cholesterol triglycerides 54 glucose intolerance 54 immunocompromised individuals 54 soluble CD# ligand 54 inhaled glucocorticoids 54 NSAID associated 54 hereditary pancreatitis 54 nonfatal stroke 54 severe hypoglycaemia 54 etiologic factors 54 embolic stroke 54 nontraumatic 54 obstructive coronary 54 glycosylated hemoglobin levels 54 silent ischemia 54 airway responsiveness 54 serum lipid 54 MTHFD1L gene 54 MYH9 gene 54 macroalbuminuria 54 Sugar sweetened beverages 54 susceptibility loci 54 MYH9 54 thyroid dysfunction 54 oesophageal adenocarcinoma 54 hyperphenylalaninemia HPA due 54 HIV HCV coinfected 54 left ventricular diastolic 54 folate concentrations 54 Oxidative damage 54 pretransplant 54 NSAID induced GI 54 % CI #.#-#.# [004] 54 LVSD 54 glucose triglycerides 54 % CI #.#-#.# [008] 54 APOE genotype 54 thyrotropin levels 54 Fasting blood glucose 54 Alzheimer disease vascular dementia 54 abnormal genital 54 asplenia 54 antiphospholipid syndrome 54 inotropic agents 54 abnormal clotting 54 postprandial hyperglycemia 54 natriuresis 54 left ventricular systolic 54 HDL2 54 affective psychoses 54 CHD coronary 54 Sleep disturbances 54 recurrent acute pancreatitis 54 mixed hyperlipidemia 54 Uncontrolled diabetes 54 density lipoprotein cholesterol 54 epilepsy Parkinson disease 54 prenatal exposures 54 Hp2 2 54 hepatic steatosis 54 lupus scleroderma 54 elevated LDL cholesterol 54 sociodemographic variables 54 receptor gamma 54 Subgroup analyzes 54 Chronic pancreatitis 54 umol L 54 Serum concentrations 54 inflammatory rheumatic 54 NIDDM 54 Left ventricular hypertrophy 54 leiomyomas 54 lowering triglyceride levels 54 Primary endpoints 54 colorectal carcinogenesis 54 non valvular atrial 54 LRP5 54 arterial stenosis 54 parous women 54 systolic dysfunction 54 subclinical hyperthyroidism 54 impaired endothelial 54 diabetes cardiovascular disease 54 carotid plaque 54 metabolic abnormality 54 Cotinine 54 stratifying patients 54 morphometric vertebral fractures 54 salivary cotinine 54 polyp recurrence 54 intraoperative complications 54 hypertensive disorders 54 Uncontrolled hypertension 54 thyroid deficiency 54 perioperative complications 54 hepatic lipid 54 hypertension diabetes 54 anthropometric measures 54 emphysema bronchitis 54 postoperative delirium 54 HLA DRB1 SE 54 Invasive pneumococcal disease 54 SGPT 54 deep vein thromboses 54 anovulatory infertility 54 dermatologic reactions 54 Premature menopause 54 coma convulsions 54 chorioamnionitis 54 serum parathyroid hormone 54 chromosome #q# [002] 54 cardio metabolic 54 CHD mortality 54 gestational hypertension 54 Prehypertension 54 body fatness 54 IDDM 54 Comorbid 54 COPD emphysema 53 subclinical hypothyroidism 53 perinatal complications 53 psychiatric comorbidity 53 haematologic 53 autoantibody levels 53 cardiovascular disease osteoporosis 53 collagen vascular 53 antihistamine medicines 53 coexisting illnesses 53 elevated lipase 53 externalizing disorders 53 atherosclerotic cardiovascular disease 53 plasma adiponectin 53 vitamin B1 deficiency 53 causally linked 53 intestinal permeability 53 histological subtype 53 infertility miscarriage 53 congenital abnormalities 53 metformin sulfonylureas 53 neonatal morbidity 53 microbleeds 53 carbohydrate metabolism 53 rhythm disturbances 53 rheumatoid arthritis inflammatory bowel 53 vascular constriction 53 Thyroid hormone 53 idiopathic pulmonary arterial hypertension 53 coagulation abnormalities 53 Exclusion criteria 53 precursor lesions 53 nonfatal cardiac arrest 53 contrast induced nephropathy 53 Glucocorticoids 53 cardio metabolic diseases 53 Intra abdominal 53 leptin resistant 53 recurrent venous thromboembolism 53 gestational diabetes mellitus GDM 53 cardiomyopathies 53 System IPSS 53 echocardiographic parameters 53 cardiometabolic disorders 53 intracerebral 53 acute myocardial infarction MI 53 anticholinergic agents 53 Thyroid disorders 53 serum cholesterol 53 familial clustering 53 kidney urologic 53 primary aldosteronism 53 INTERHEART study 53 carotid stenosis 53 triacylglycerol concentrations 53 calcium antagonists 53 IPAH 53 diabetes mellitus 53 pulmonary dysfunction 53 plasma lipid 53 oral antidiabetic agents 53 microvascular complications 53 nondiabetic 53 HER2 overexpression 53 subclinical disease 53 multivariate adjustment 53 inflammatory autoimmune diseases 53 recurrent miscarriage 53 abnormal glucose metabolism 53 aldosterone hormone 53 Arrhythmogenic Right Ventricular Cardiomyopathy 53 proband 53 airway hyperresponsiveness 53 unstable angina pectoris 53 tamoxifen Nolvadex ® 53 recurrent ischemia 53 carotid artery blockage 53 Fasting glucose 53 antihypertensive medication 53 atherosclerosis plaque buildup 53 noncardiovascular 53 aldosterone antagonist 53 esophagus colon 53 AVAPRO 53 hypoglycemic events 53 #mg sodium #mg [002] 53 untreated celiac disease 53 diabetes mellitus DM 53 tertiles 53 nonselective NSAIDs 53 newer atypical antipsychotics 53 GRK5 53 atherosclerotic progression 53 cholestasis 53 triglyceride concentrations 53 recurrent UTI 53 lipid profiles 53 fasting insulin 53 maintaining cardiorespiratory fitness 53 patients undergoing percutaneous 53 SIADH 53 post partum hemorrhage 53 Non Alcoholic Fatty 53 Angiotensin converting enzyme 53 neuroinflammatory 53 serine proteases 53 cryptogenic 53 HBeAg negative 53 secondary hyperparathyroidism 53 VTE prophylaxis 53 ACTOplus met XR 53 arterial thromboembolic events 53 thiazide diuretic 53 Unsaturated fats 53 CP CPPS 53 arterial hypertension 53 prefrontal cortical 53 genetic polymorphism 53 morbidity mortality 53 Jingzhong Ding 53 comorbidities 53 Events MACE 53 myocardial ischemia 53 impaired glucose tolerance 53 hypertension 53 serum uric acid 53 hyperuricaemia 53 Bacterial vaginosis 53 levodopa induced 53 mechanically ventilated patients 53 thrombotic events 53 hyperinsulinism 53 hypercalcaemia 53 nondiabetic patients 53 hemoglobin A1c levels 53 myopathy rhabdomyolysis 53 cytokines chemokines 53 either acutely decompensated 53 reinfarction 53 nonfasting triglycerides 53 HbA 1c levels 53 Atkins dieters cardiovascular 53 improves insulin sensitivity 53 serum PTH 53 oral antidiabetic drugs 53 % CI #.#-#.# [006] 53 maternal morbidity 53 atrophic gastritis 53 gastric carcinogenesis 53 Mitral valve 53 cerebral infarction 53 Warfarin Coumadin 53 thymectomy 53 fructosamine 53 mortality morbidity 53 bladder cervix 53 hyperinsulinemia 53 obstetric complications 53 prolonged immobilization 53 Hypertensive 53 Colon polyps 53 hypertriglyceridemia 53 renal fibrosis 53 kg m² 53 quetiapine Seroquel 53 2 diabetes UKPDS 53 Impaired Glucose Tolerance 53 myeloproliferative neoplasms 53 dietary folate 53 induced hypoglycemia 53 Secondhand smoke causes 53 hypopneas 53 Rh incompatibility 53 cTnT 53 multivariate analyzes 53 HMG CoA reductase inhibitors 53 blindness amputation 53 Univariate analysis 53 STEMIs 53 CYP#D# gene 53 S6K 53 cerebral oxygenation 53 Statin therapy 53 seizures comas 52 CDH1 52 untreated OSA 52 atherosclerotic disease 52 myocardial oxygen 52 tryptase 52 statins cholesterol lowering 52 HLA DRB1 52 diastolic BP 52 alcoholic fatty liver 52 sudden coronary thrombosis 52 coronary vascular 52 Insulin resistance 52 apo B 52 cardio vascular disease 52 congential 52 Low birthweight 52 obese postmenopausal 52 renal scarring 52 use disorders AUDs 52 incomplete revascularization 52 thiazide 52 stroke transient ischemic 52 tumor lysis syndrome 52 internalizing disorders 52 lipid metabolism 52 Aortic stenosis 52 eczema asthma 52 Radiographic findings 52 comorbid anxiety 52 orofacial clefts 52 arachidonic acid AA 52 tumor histology 52 cardiac dysfunction 52 diabetes mellitus T2DM 52 anticoagulant warfarin 52 nonfatal MI 52 covariates 52 hypercholesterolemia 52 sensory gating 52 genetic polymorphisms 52 CYT# potent vascular disrupting 52 basal cell nevus syndrome 52 thyrotoxicosis 52 coronary atherosclerosis 52 poor metabolizers 52 pancreatic endocrine 52 coinfection 52 albumin excretion rate 52 visceral fat accumulation 52 systemic autoimmune 52 Dental caries 52 rheumatoid arthritis osteoarthritis ankylosing 52 artery elasticity 52 nonhereditary 52 Pelvic inflammatory 52 heterozygous familial 52 etiological 52 Excessive daytime sleepiness 52 CYP #A# 52 mild renal impairment 52 nasopharyngitis headache 52 nondiabetics 52 pancreatic prostate 52 microalbuminuria 52 intra abdominal abscess 52 hypothalamic pituitary adrenal axis 52 LDL cholesterol triglycerides 52 obstructive sleep apnea hypopnea 52 adiponectin concentrations 52 gastrointestinal disturbances 52 emphysema chronic bronchitis 52 proinflammatory 52 cardiac conduction 52 sinus node dysfunction 52 cerebrovascular accidents 52 Intracerebral hemorrhage 52 GH deficiency 52 coronary heart 52 insulin secretagogue 52 atherosclerotic coronary 52 insomnia somnolence 52 heparin induced thrombocytopenia 52 hypertension hyperlipidemia 52 intraventricular hemorrhage 52 fats lipids 52 syncope fainting 52 C1 INH deficiency 52 thickness IMT 52 variceal bleeding 52 bronchodilator therapy 52 pulmonary capillary wedge 52 tic severity 52 edema thrombosis pulmonary thromboembolism 52 Chronic inflammation 52 Hemorrhagic stroke 52 diabetes hypertension 52 chromosome #p# [002] 52 T2DM 52 unexplained vaginal bleeding 52 cerebral microbleeds 52 urinary bladder infections 52 adiponectin levels 52 chromosomal disorders 52 thiazide diuretics 52 metabolizing enzyme 52 atypical ductal hyperplasia 52 acute ischemia 52 cerebral perfusion 52 Stop Hypertension diet 52 thiazolidinediones TZDs 52 colorectal cancer CRC 52 lipid lowering medications 52 symptomatic hyponatremia 52 upper aerodigestive tract 52 CrCl 52 advanced neoplasia 52 sociodemographic 52 comorbid disorders 52 CNS systemic embolism 52 depressive symptomatology 52 prostate colon 52 latent celiac disease 52 low birthweight infants 52 cardiovascular disease 52 thrombotic complications 52 multivariate logistic regression 52 milli grams 52 Wernicke encephalopathy 52 obstructive lung 52 metformin sulfonylurea 52 hyperparathyroidism 52 PON1 52 insulin resistance 52 renal dysfunction 52 normotensive 52 HCV antibody 52 hormone adiponectin 52 Modifiable risk 52 ventilation perfusion 52 bacteriuria 52 plasminogen activator inhibitor 52 oral cavity pharynx larynx 52 TNF blocker therapy 52 chronic immune thrombocytopenic 52 hepatic cirrhosis 52 lipoprotein profiles 52 nondemented 52 serum bicarbonate 52 coagulopathy 52 eicosanoids 52 catheter angiography 52 vascular inflammation 52 congenital anomalies 52 HDL LDL ratio 52 STK# gene 52 hypophosphatemia 52 multivariable adjusted 52 Diabetic nephropathy 52 recurrent DVT 52 AGGRASTAT R tirofiban hydrochloride 52 tumor necrosis 52 carbohydrate intolerance 52 CETP gene 52 Apolipoprotein E 52 perimenopausal women 52 endocrine abnormalities 52 acarbose 52 mmHg diastolic 52 coronary stenosis 52 Adequate vitamin D 52 Wernicke Korsakoff syndrome 52 Epidemiologic studies 52 5 HT1A receptor 52 nonvascular 52 surgically induced 52 coadministration 52 atopic disorders 52 cerebrovascular disease 52 abnormal blood clotting 52 medication nonadherence 52 androgen excess 52 hydroxyvitamin D levels 52 Coronary artery calcium 52 socioeconomic deprivation 52 orthostatic hypotension cataracts 52 neutropenia thrombocytopenia 52 haloperidol Haldol 52 nephrolithiasis 52 VLBW 52 coronary revascularizations 52 myocardial infarctions MIs 52 Adenoviruses usually cause 52 myocardial infarction 52 fasting lipid 52 AI AN 52 hepatocellular carcinoma liver 52 testicular germ cell 52 urolithiasis 52 induced cardiomyopathy 52 NAFLD 52 pyrexia mucositis sepsis febrile 52 OSAHS 52 Wheelchair accessible valet parking 52 inflammatory markers 52 beta carotene supplementation 52 hsCRP levels 52 Socioeconomic factors 52 hyperkalemia 52 glucose intolerant 52 NSAID induced 52 unmeasured factors 52 prognostic indicators 52 psychiatric morbidity 52 neurologic complications 52 angiotensin converting enzyme inhibitor 52 hemodilution 52 Apolipoprotein E4 52 prostate abnormalities 52 inotropic 52 intracranial hemorrhage ICH 52 deep venous thromboses 52 hypercapnia 52 cystic fibrosis sickle cell 52 slow metabolizers 52 gene polymorphisms 52 AUDs 52 dopamine D2 receptors 52 confidence interval CI 52 mild hepatic impairment 52 polycystic ovary 52 peripheral insulin sensitivity 52 aMCI precursor 52 adiposity 52 logistic regression analysis 52 fasting triglyceride levels 52 Socioeconomic status 52 acute myocardial infarction AMI 52 postoperative infections 52 metabolic syndrome MetS 52 psychopathological disorders 52 microangiopathy 52 Viral infections 52 ACE Inhibitor 52 recurrent myocardial infarction 52 Elevated serum 52 comorbid substance 52 nonvertebral fracture 52 postoperative morbidity 52 cardiac troponin T 52 bioavailable testosterone 52 androgen therapy 52 affective psychosis 52 hydroxymethyl coenzyme 52 occlusive disease 52 serum lipids 52 HbF 52 anticoagulants blood thinners 52 indicates cardio circulatory 52 hepatic insufficiency 52 atherosclerosis narrowing 52 Undesirable alterations 52 alpha interferons 52 Chronic renal failure 52 psychosocial functioning 52 gastro oesophageal reflux 52 cardiovascular cerebrovascular 52 cryptogenic stroke 52 LDL HDL 52 tremors numbness 52 serum cotinine levels 52 renal artery stenosis 52 cardiometabolic syndrome 52 myocardial fibrosis 52 EGFR mutation status 52 atherosclerosis myocardial infarction 52 Obstructive sleep apnea OSA 51 patients undergoing CABG 51 hepatocellular 51 familial adenomatous polyposis FAP 51 atherothrombotic disease 51 chronic eosinophilic leukemia 51 Vitamin D insufficiency 51 type2 diabetes 51 Fatty liver 51 polymorphic ventricular tachycardia 51 obstructive sleep 51 pulmonary emphysema 51 dose atorvastatin 51 cerebral infarctions 51 socioeconomic gradient 51 abdominally obese 51 Elevated cholesterol 51 obstructive airway disease 51 endogenous estrogen 51 arterial stiffness 51 glitazones 51 listed hypertensive cardiovascular 51 hMG 51 apolipoprotein E gene 51 Subclinical 51 teratogens 51 strongest predictors 51 trophoblastic 51 genetic loci 51 extrapulmonary 51 receptor subtypes 51 abstinent alcoholics 51 Hypertriglyceridemia 51 eczema hay fever 51 GABRA2 51 allergic eczema 51 #q# deletion syndrome 51 neurocognitive function 51 normal karyotype 51 Acute pancreatitis 51 Hemolytic uremic syndrome 51 hereditary hemochromatosis 51 Gestational 51 Thromboembolic 51 metabolizing enzymes 51 colonic polyps 51 NPH insulin 51 inducible nitric oxide synthase 51 severe obstructive pulmonary 51 VLDL C 51 adenomatous 51 biphasic insulin aspart 51 arteries atherosclerosis 51 hypogonadotropic hypogonadism 51 hypoglycemic episodes 51 neurocognitive functioning 51 covariate 51 hypothalamic pituitary 51 Non communicable diseases 51 prostate testicular 51 vasodilatation 51 physical inactivity 51 keloid scarring treatment 51 habitual snoring 51 postoperative atrial fibrillation 51 venous thrombotic events 51 IGRAs 51 Djousse 51 Atherosclerotic 51 Lp PLA 2 51 amputations blindness 51 delta gamma agonist 51 BMI percentiles 51 Thrombotic thromboembolic complications 51 airflow limitation 51 CTAP# Capsules